4SARPAL R,NEEDHAM D.Binding of paclitaxel to lipid interfaces:correlations with interface compliance[J].J Liposome Res,1998(8):147-164.
5PERKINS W R,AHMAD I,LIX,et al.Novel therapeutic nano-particles (lipocores):trapping poorly water soluble compounds[J].Int J Pharm,2000,200(1):27-39.
6CROSASSO P,CERUTI M,BRUSA P,et al.Preparation,characterization and properties of sterically stabilized paclitaxel-containing liposomes[J].J Control Rel,2000,63(1/2):19-30.
7CROSASSO P,CERUTI M,BRUSA P,et al.Preparation,characterization,cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel[J].J Control Rel,2000,63:141-153.
8KANG B K,CHON S K,KIM S H,et al.Controlled release of paclitaxel from microemulsion containing PLGA and evalurtion of anti-tumor activity in vitro and invivo[J].Int J Pharm,2004,286(1/2):147-156.
9LE GARREC D,GORI S,LUO L,et al.Poly(N-vinylpyrrolidone)-block-poly-(D,L-lactide) as a new poly meric solubilizer for hydrophobic anticancer drugs:in vitro and in vivo evaluation[J].J Control Release,2004,99(1):83-101.
10ZHANG X C,BURT H M,HOFF D V,et al.An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel[J].Cancer Chemother Pharmacol,1997,40:81-86.
